Abstract:Objective. To investigate the expression of kinesin family member 20A (KIF20A) in bladder cancer, the effect of KIF20A on the proliferation and metastasis of bladder cancer cells, and the effect of KIF20A expression on the prognosis of bladder cancer patients. Methods. Bladder cancer tissue and its adjacent tissues were collected from tumour patients. The mRNA and protein expression levels of KIF20A in the tissue samples were detected by qRT-PCR and western blot. Immunohistochemical (IHC) staining was used to identify the expression and distribution of KIF20A proteins in the tissue samples. The relationship between the KIF20A expression and the clinical pathology of bladder cancer was analysed. The effect of the differential expression of KIF20A on the prognosis of patients with bladder cancer was analysed by the TCGA database. The plasmid was transfected into the bladder cell lines T24 and 5637 to construct two stable cell lines with knocked down KIF20A. The effect of KIF20A expression on the proliferation and invasion of T24 and 5637 bladder cells was explored in vitro using the abovementioned stable cell lines. The effect of the KIF20A expression on the proliferation of bladder cancer cells was evaluated by a mouse xenograft model. Results. The expression of KIF20A was significantly higher in the bladder cancer tissues than in the adjacent control tissues. The expression of KIF20A was significantly associated with the degree of pathological differentiation of bladder cancer. Patients with a higher expression of KIF20A had a higher tumour grade and a more advanced stage. The mean survival of patients with a high KIF20A expression was significantly lower than the mean survival of patients with a low KIF20A expression. The in vitro experiments demonstrated that the knockdown of KIF20A significantly inhibited T24 and 5637 cell proliferation and invasion. The in vivo experiments showed that the knockdown of KIF20A significantly inhibited the proliferation of the bladder tumours. Conclusion. KIF20A promotes the proliferation and metastasis of bladder cancer cells. Bladder cancer patients with a high KIF20A expression have a worse tumour differentiation and a poor prognosis. KIF20A may become an independent factor that affects the prognosis of bladder cancer patients and a therapeutic target for bladder cancer.

Retracted: KIF20A Silence Inhibits the Migration, Invasion and Proliferation of Non‐small Cell Lung Cancer and Regulates the JNK Pathway

MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.

The Molecular Mechanism of Kinesin Family Member 2A (KIF2A) Underlying Non-Small Cell Lung Cancer: the Effect of Its Knockdown on Malignant Behaviors, Stemness, Chemosensitivity, and Potential Regulated Signaling Pathways.

Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis

The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer.

The influence of silence KIF20A gene on the proliferation,invasion and metastasis ability of human hepatocellular carcinoma cell line SMCC - 7721

Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome

KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K/AKT signaling pathway

Overexpression Of Kinesin Family Member 20a Correlates With Disease Progression And Poor Prognosis In Human Nasopharyngeal Cancer: A Retrospective Analysis Of 105 Patients

A pan-cancer exploration of kinesin family member 20A (KIF20A)'s oncogenic activity in human tumors

Silencing of KIF18B Restricts Proliferation and Invasion and Enhances the Chemosensitivity of Breast Cancer Via Modulating Akt/GSK‐3β/β‐catenin Pathway

KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.

KIFC3 promotes the progression of non-small cell lung cancer cells through the PI3K/Akt pathway

Preliminary Study on the Clinical Significance of Kinesin Kif18a in Nonsmall Cell Lung Cancer: an Analysis of 100 Cases.

Kctd20 Promotes the Development of Non‐small Cell Lung Cancer Through Activating Fak/AKT Pathway and Predicts Poor Overall Survival of Patients

Increased Kif15 Expression Predicts A Poor Prognosis In Patients With Lung Adenocarcinoma

Kif2a Silencing Inhibits the Proliferation and Migration of Breast Cancer Cells and Correlates with Unfavorable Prognosis in Breast Cancer

KIF20A Promotes CRC Progression and the Warburg Effect through the C-Myc/HIF-1α Axis

KIF18A Promotes Head and Neck Squamous Cell Carcinoma Invasion and Migration Via Activation of Akt Signaling Pathway

KIF20B Promotes the Progression of Clear Cell Renal Cell Carcinoma by Stimulating Cell Proliferation

An evaluation of KIF20A as a prognostic factor and therapeutic target for lung adenocarcinoma using integrated bioinformatics analysis